For Sangamo Therapeutics, science is a means to develop new medicines to transform the lives of patients living with serious genetic diseases.
With 21 years of experience, Sangamo is a pioneer in research and development of new gene-based therapies.
We seek to gain perspectives from patients, caregivers and their advocates in order to understand the daily challenges of those we are here to serve.
Industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation
News + Events
2018 Wedbush PacGrow Healthcare Conference
Sangamo Therapeutics Announces Presentation At The 2018 Wedbush PacGrow Healthcare Conference
Sangamo Therapeutics Reports Second Quarter 2018 Financial Results